Stocktoria

Bioquest Corp BQST

OTC · stock · Pharmaceutical Preparations · website · IPO 2013-09-26

Bioquest Corp statistics & valuation

Market cap$2.0M

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201320132013201420142014202020212022
Operating margin (%)
201320132013201420142014202020212022
Return on equity (%)
-91.70% -390.60% -2592.40% -1830.70% -55.80% -72.00% 201320132013201420142014202020212022
Shares outstanding
54.1M 54.1M 54.1M 54.1M 54.1M 62.1M 8.0M 8.7M 11.3M 201320132013201420142014202020212022
Net debt ($)
201320132013201420142014202020212022
Share buybacks ($)
201320132013201420142014202020212022
Return on assets (%)
-90.70% -380.90% -2275.40% -1664.40% -54.80% -66.70% -216282.50% -13592.80% -2447.90% 201320132013201420142014202020212022
Free cash flow margin (%)
201320132013201420142014202020212022
Debt / equity (×)
201320132013201420142014202020212022
EPS ($)
201320132013201420142014202020212022

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2022FY2021FY2020FY2014FY2014FY2014FY2013FY2013FY2013
Return on assets-2447.9%-13592.8%-216282.5%-66.7%-54.8%-1664.4%-2275.4%-380.9%-90.7%
Return on equity189.6%131.3%259.1%-72.0%-55.8%-1830.7%-2592.4%-390.6%-91.7%
Current ratio0.070.010.003.6460.54———78.99

Computed from company filings · US · as of 2022-04-30. Facts plus Stocktoria's own computed scores — not investment advice.